The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation
Open accessAbstract
Despite a growing understanding of the link between intestinal inflammation and resident gut microbes, longitudinal studies of human flora before initial onset of intestinal inflammation have not been reported. Here, we demonstrate in murine and human recipients of allogeneic bone marrow transplantation (BMT) that intestinal inflammation secondary to graft-versus-host disease (GVHD) is associated with major shifts in the composition of the intestinal microbiota. The microbiota, in turn, can modulate the severity of intestinal inflammation. In mouse models of GVHD, we observed loss of overall diversity and expansion of Lactobacillales and loss of Clostridiales. Eliminating Lactobacillales from the flora of mice before BMT aggravated GVHD, whereas reintroducing the predominant species of Lactobacillus mediated significant protection against GVHD. We then characterized gut flora of patients during onset of intestinal inflammation caused by GVHD and found patterns mirroring those in mice. We also identified increased microbial chaos early after allogeneic BMT as a potential risk factor for subsequent GVHD. Together, these data demonstrate regulation of flora by intestinal inflammation and suggest that flora manipulation may reduce intestinal inflammation and improve outcomes for allogeneic BMT recipients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preclinical models have shown that commensal bacteria influence the pathophysiology of GVHD.10,17–20”
From Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation (2020) · cites this paper as [19]
In the citing paper
“The onset of acute-GVHD is associated with significant shifts in the composition of the microbiota with a loss of overall diversity and reduction of health-promoting obligate anaerobes such as Faecalibacterium, Ruminococcus, Lactobacillus, and Blautia, and an enrichment of Enterococcus and Clostridiales”
From The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy (2018) · cites this paper as Jenq et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 21,481
Naive Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 20,145
Measuring biological diversity
Magurran, A. E. (2004) · Choice Reviews Online · doi:10.5860/choice.42-1547 · Cited by 6,617
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182
Human nutrition, the gut microbiome and the immune system
Kau, A. L., Ahern, P. P., Griffin, N. W., Goodman, A. L., & Gordon, J. I. (2011) · Nature · doi:10.1038/nature10213 · Cited by 2,588
Ferrara, J. L. M., Levine, J. E., Reddy, P. R., & Holler, E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60237-3 · Cited by 2,508
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361
Intestinal homeostasis and its breakdown in inflammatory bowel disease
Maloy, K. J., & Powrie, F. M. (2011) · Nature · doi:10.1038/nature10208 · Cited by 1,911
UniFrac – An online tool for comparing microbial community diversity in a phylogenetic context
Lozupone, C., Hamady, M., & Knight, R. D. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-371 · Cited by 1,454
Cooke, K., Kobzik, L., Martin, T., Brewer, J., Delmonte, J., Crawford, J., & Ferrara, J. (1996) · Blood · doi:10.1182/blood.v88.8.3230.bloodjournal8883230 · Cited by 967
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 624
Riwes, M. M., Golob, J. L., Magenau, J. M., Shan, M., Dick, G. J., Braun, T., Schmidt, T. M., Pawarode, A., Anand, S. M., Ghosh, M., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02587-y · Cited by 52
Tingler, A. M., & Engevik, M. A. (2025) · Infection and Immunity · doi:10.1128/iai.00503-24 · Cited by 58
Harnessing the Intestinal Microbiome for Optimal Therapeutic Immunomodulation
Viaud, S., Daillère, R., Boneca, I. G., Lepage, P., Pittet, M. J., Ghiringhelli, F., Trinchieri, G., Goldszmid, R. S., & Zitvogel, L. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0987 · Cited by 48
Reversing Gut Damage in HIV Infection: Using Non-Human Primate Models to Instruct Clinical Research
Ponte, R., Mehraj, V., Ghali, P., Couëdel-Courteille, A., Cheynier, R., & Routy, J. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.01.028 · Cited by 46
Scheich, S., Lindner, S., Koenig, R., Reinheimer, C., Wichelhaus, T. A., Hogardt, M., Besier, S. M., Kempf, V. A. J., Kessel, J. M., Martin, H., et al. (2017) · Cancer · doi:10.1002/cncr.31045 · Cited by 47
Complex interactions between the microbiome and cancer immune therapy
Schwartz, D. J., Rebeck, O. N., & Dantas, G. A. (2019) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1660303 · Cited by 52
Graft-versus-host disease biomarkers: omics and personalized medicine
Paczesny, S., Raiker, N. K., Brooks, S., & Mumaw, C. (2013) · International Journal of Hematology · doi:10.1007/s12185-013-1406-9 · Cited by 47
Ferrara, J. L. M., & Chaudhry, M. S. (2018) · Hematology · doi:10.1182/asheducation-2018.1.221 · Cited by 46
Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathology
Fujiwara, H., Seike, K., Brooks, M. D., Mathew, A. V., Kovalenko, I., Pal, A., Lee, H., Peltier, D., Kim, S. H., Liu, C., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-01048-3 · Cited by 45
Self-citationYazdandoust, E., Hajifathali, A., Roshandel, E., Zarif, M. N., Pourfathollah, A. A., Parkhideh, S., Mehdizadeh, M., & Amini‐Kafiabad, S. (2023) · Transplant Immunology · doi:10.1016/j.trim.2023.101836 · Cited by 45
Alverdy, J. C., & Luo, J. N. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00322 · Cited by 47
Song, M., & Chan, A. T. (2017) · Current Colorectal Cancer Reports · doi:10.1007/s11888-017-0389-y · Cited by 50
Liao, C., Taylor, B. P., Ceccarani, C., Fontana, E., Amoretti, L. A., Wright, R. J., Gomes, A. L. C., Peled, J. U., Taur, Y., Perales, M., et al. (2021) · Scientific Data · doi:10.1038/s41597-021-00860-8 · Cited by 45
Self-citationPathogenesis and therapy of radiation enteritis with gut microbiota
Yang, Q., Qin, B., Hou, W., Qin, H., & Yin, F.-F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1116558 · Cited by 44
Gea‐Banacloche, J., Komanduri, K. V., Carpenter, P. A., Paczesny, S., Sarantopoulos, S., Young, J. H., Kassar, N. E., Le, R. Q., Schultz, K. R., Griffith, L. M., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.10.001 · Cited by 44
Ferrara, J. L. M., Smith, C. M., Sheets, J., Reddy, P. R., & Serody, J. S. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90592 · Cited by 45
Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitis
Riwes, M. M., & Reddy, P. (2020) · Seminars in Hematology · doi:10.1053/j.seminhematol.2020.06.001 · Cited by 44
Immunomodulatory and Regenerative Effects of MSC-Derived Extracellular Vesicles to Treat Acute GVHD
Fujii, S., & Miura, Y. (2022) · Stem Cells · doi:10.1093/stmcls/sxac057 · Cited by 47
Targeting the IL17 Pathway for the Prevention of Graft-Versus-Host Disease
van der Waart, A. B., van der Velden, W. J. F. M., Blijlevens, N. M. A., & Dolstra, H. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.02.007 · Cited by 43
Host NLRP6 exacerbates graft-versus-host disease independent of gut microbial composition
Toubai, T., Fujiwara, H., Rossi, C., Riwes, M. M., Tamaki, H., Zajac, C. K., Liu, C., Mathew, A. V., Byun, J., Oravecz-Wilson, K. I., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0373-1 · Cited by 45
Self-citationInsights into the role of intestinal microbiota in hematopoietic stem-cell transplantation
Zama, D., Bossù, G., Leardini, D., Muratore, E., Biagi, E., Prete, A., Pession, A., & Masetti, R. (2020) · Therapeutic Advances in Hematology · doi:10.1177/2040620719896961 · Cited by 45
Insights into the role of the JAK/STAT signaling pathway in graft- versus -host disease
Abboud, R., Choi, J., Ruminski, P., Schroeder, M. A., Kim, S., Abboud, C. N., & DiPersio, J. F. (2020) · Therapeutic Advances in Hematology · doi:10.1177/2040620720914489 · Cited by 44
Wang, L., Pan, M., Li, D., Yin, Y., Jiang, T., Fang, S., Wang, G., Zhao, J., Zhang, H., & Chen, W. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.09.045 · Cited by 43
Socié, G., Kean, L. S., Zeiser, R., & Blazar, B. R. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149296 · Cited by 42
Self-citationFacts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy
Davar, D., & Zarour, H. M. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1129 · Cited by 40
Buxbaum, N. P., Socié, G., Hill, G. R., MacDonald, K. P. A., Tkachev, V., Teshima, T., Lee, S. J., Ritz, J., Sarantopoulos, S., Luznik, L., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007611 · Cited by 41
Self-citationSeike, K., Kiledal, E. A., Fujiwara, H., Henig, I. J., da Silva, M. B., van den Brink, M. R. M., Hein, R., Hoostal, M. J., Liu, C., Oravecz-Wilson, K. I., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.007 · Cited by 46
Self-citationMorrisette, T., Matre, A. V., Miller, M. A., Mueller, S. W., Bajrovic, V., Abidi, M. Z., Benamu, E., Kaiser, J. N., Barber, G. R., Chase, S., et al. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.06.021 · Cited by 41
Rashidi, A., Gao, F., Fredricks, D. N., Pergam, S. A., Mielcarek, M. B., Milano, F., Sandmaier, B. M., & Lee, S. J. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.17188 · Cited by 40
Gut microbiota, microbiota‐derived metabolites, and graft‐versus‐host disease
Yue, X., Zhou, H., Wang, S., Chen, X., & Xiao, H. (2024) · Cancer Medicine · doi:10.1002/cam4.6799 · Cited by 45
Changes in intestinal microbiota and their effects on allogeneic stem cell transplantation
Shallis, R. M., Terry, C., & Lim, S. H. (2017) · American Journal of Hematology · doi:10.1002/ajh.24896 · Cited by 40
Dubberke, E. R., Reske, K. A., Olsen, M. A. A., Bommarito, K. M., Cleveland, A. A., Silveira, F. P., Schuster, M. G., Kauffman, C. A., Avery, R. K., Pappas, P. G., et al. (2018) · Transplant Infectious Disease · doi:10.1111/tid.12855 · Cited by 40
Diefenbach, C., Peters, B. A., Li, H., Raphael, B. G., Moskovits, T., Hymes, K. B., Schlüter, J., Chen, J., Bennani, N. N., Witzig, T. E., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003129 · Cited by 41
Hidaka, D., Hayase, E., Shiratori, S., Hasegawa, Y., Ishio, T., Tateno, T., Okada, K., Goto, H., Sugita, J., Onozawa, M., et al. (2018) · Clinical Transplantation · doi:10.1111/ctr.13361 · Cited by 39
Orberg, E. T., Meedt, E., Hiergeist, A., Xue, J., Heinrich, P., Ru, J., Ghimire, S., Miltiadous, O., Lindner, S., Tiefgraber, M., et al. (2024) · Nature Cancer · doi:10.1038/s43018-023-00669-x · Cited by 46
Gavriilaki, M., Sakellari, I., Anagnostopoulos, Α., & Gavriilaki, E. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.05.011 · Cited by 39
Chen, C., Su, Q., Zi, M., Hua, X., & Zhang, Z. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00818-3 · Cited by 45
Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease
Thangavelu, G., & Blazar, B. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00309 · Cited by 37
Self-citationHong, T., Wang, R., Wang, X., Yang, S., Wang, W., Gao, Q., & Zhang, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.644982 · Cited by 38
Goeser, F., Sifft, B., Stein‐Thoeringer, C. K., Farowski, F., Strassburg, C. P., Brossart, P., Higgins, P. G., Scheid, C., Wolf, D. G. F., Holderried, T. A. W., et al. (2021) · European Journal Of Haematology · doi:10.1111/ejh.13642 · Cited by 39
The influence of the microbiota on the immune response to transplantation
Bartman, C., Chong, A. S., & Alegre, M. (2015) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000150 · Cited by 39
Masetti, R., Zama, D., Leardini, D., Muratore, E., Turroni, S., Prete, A., Brigidi, P., & Pession, A. (2020) · Pediatric Blood & Cancer · doi:10.1002/pbc.28711 · Cited by 37
Liu, Y., Zhao, Y., Qi, J., Ma, X., Qi, X., Wu, D., & Xu, Y. (2022) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00350-6 · Cited by 37
Insights into the pathogenesis of GvHD : what mice can teach us about man
Hülsdünker, J., & Zeiser, R. (2014) · Tissue Antigens · doi:10.1111/tan.12497 · Cited by 35
The where and when of T cell regulation in transplantation
Issa, F., Robb, R. J., & Wood, K. J. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.11.003 · Cited by 36
The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome
Xue, X., Li, R., Chen, Z., Li, G., Liu, B., Guo, S., Yue, Q., Yang, S., Xie, L., Zhang, Y., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1235827 · Cited by 37
The Role of Intestinal Microbiota in Acute Graft-versus-Host Disease
Chen, Y., Zhao, Y., Cheng, Q., Wu, D., & Liu, H. (2015) · Journal of Immunology Research · doi:10.1155/2015/145859 · Cited by 37
Mori, Y., Yoshimoto, G., Nishida, R., Sugio, T., Miyawaki, K., Shima, T., Nagasaki, Y., Miyake, N., Harada, Y., Kunisaki, Y., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.06.002 · Cited by 35
Safety of Probiotics Among High-Risk Pediatric Hematopoietic Stem Cell Transplant Recipients
Sadanand, A., Newland, J. G., & Bednarski, J. J. (2019) · Infectious Diseases and Therapy · doi:10.1007/s40121-019-0244-3 · Cited by 35
IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease
Henden, A. S., Koyama, M., Robb, R. J., Forero, A., Kuns, R. D., Chang, K., Ensbey, K. S., Varelias, A., Kazakoff, S. H., Waddell, N., et al. (2021) · Blood · doi:10.1182/blood.2020006375 · Cited by 34
Self-citationHülsdünker, J., Thomas, O. S., Haring, E., Unger, S., Núñez, N. G., Tugues, S., Gao, Z., Duquesne, S., Cywes‐Bentley, C., Oyardı, Ö., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908549116 · Cited by 34
New therapeutic targets and biomarkers for acute graft-versus-host disease (GVHD)
Choe, H. K., & Ferrara, J. L. M. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1992383 · Cited by 34
Influence of Donor Microbiota on the Severity of Experimental Graft-versus-Host-Disease
Tawara, I., Liu, C., Tamaki, H., Toubai, T., Sun, Y., Evers, R., Nieves, E. C., Mathewson, N. D., Núñez, G., & Reddy, P. R. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2012.09.001 · Cited by 33
Self-citationThe intestinal microbiome and surgical disease
Krezalek, M. A., Skowron, K. B., Guyton, K. L., Shakhsheer, B. A., Hyoju, S. K., & Alverdy, J. C. (2016) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2016.06.001 · Cited by 35
T-Cell Metabolism in Hematopoietic Cell Transplantation
Nguyen, H. D., Kuril, S., Bastian, D. A., & Yu, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00176 · Cited by 34
Emerging role of microbiota in immunomodulation and cancer immunotherapy
Singh, R. P., Bashir, H., & Kumar, R. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.008 · Cited by 34
The Pathophysiology and Treatment of Graft-Versus-Host Disease: Lessons Learnt From Animal Models
Teshima, T., & Hill, G. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.715424 · Cited by 33
Galloway-Peña, J., Jenq, R. R., & Shelburne, S. A. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3173 · Cited by 32
Self-citationCellular therapies for graft-versus-host disease: a tale of tissue repair and tolerance
Voermans, C., & Hazenberg, M. D. (2020) · Blood · doi:10.1182/blood.2019000951 · Cited by 34
Tyrosine supplement ameliorates murine aGVHD by modulation of gut microbiome and metabolome
Li, X., Lin, Y., Li, X., Xu, X., Zhao, Y., Xu, L., Gao, Y., Li, Y., Tan, Y., Qian, P., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103048 · Cited by 34
Impact of gut microbiota on kidney transplantation
Winichakoon, P., Chaiwarith, R., Chattipakorn, N., & Chattipakorn, S. C. (2021) · Transplantation Reviews · doi:10.1016/j.trre.2021.100668 · Cited by 32
The Gut Microbiota in Causation, Detection, and Treatment of Cancer
Murphy, C. L., O’Toole, P. W., & Shanahan, F. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000075 · Cited by 34
Gut microbiota resilience and recovery after anticancer chemotherapy
Roggiani, S., Mengoli, M., Conti, G., Fabbrini, M., Brigidi, P., Barone, M., D'Amico, F., & Turroni, S. (2023) · Microbiome Research Reports · doi:10.20517/mrr.2022.23 · Cited by 31
Jarosch, S., Köhlen, J., Ghimire, S., Orberg, E. T., Hammel, M., Gaag, D., Evert, M., Janssen, K., Hiergeist, A., Gessner, A., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101125 · Cited by 34
Czech, M., Schneider, S., Peltokangas, N., Khawanky, N. E., Ghimire, S., Andrieux, G., Hülsdünker, J., Krausz, M., Proietti, M., Braun, L. M., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adi1501 · Cited by 34
Storb, R. F., Gyurkocza, B., Storer, B. E., Maloney, D. G., Sorror, M. L., Mielcarek, M. B., Martin, P. J., & Sandmaier, B. M. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.02.006 · Cited by 31
The Microbiome and Immune Regulation After Transplantation
Tabibian, J. H., & Kenderian, S. S. (2016) · Transplantation · doi:10.1097/tp.0000000000001444 · Cited by 32
Garófolo, A., Qiao, L., & Maia-Lemos, P. D. S. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2020.1797126 · Cited by 30
Next generation treatment of acute graft-versus-host disease
Magenau, J. M., & Reddy, P. R. (2014) · Leukemia · doi:10.1038/leu.2014.195 · Cited by 31
Ouyang, J., Isnard, S., Lin, J. C.-Y., Fombuena, B., Peng, X., Parvathy, S. N., Chen, Y., Silverman, M., & Routy, J. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00421 · Cited by 31
The gut microbiome in solid organ transplantation
Arassi, M. B., Zeller, G., Karcher, N., Zimmermann, M., & Tönshoff, B. (2020) · Pediatric Transplantation · doi:10.1111/petr.13866 · Cited by 27
Hematopoietic Dysfunction during Graft-Versus-Host Disease: A Self-Destructive Process?
Müskens, K. F., Lindemans, C. A., & Belderbos, M. E. (2021) · Cells · doi:10.3390/cells10082051 · Cited by 30
Jansen, S. A., Nieuwenhuis, E. E. S., Hanash, A. M., & Lindemans, C. A. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00527-6 · Cited by 30
Self-citationA review of engraftment assessments following fecal microbiota transplant
Herman, C., Barker, B. M., Bartelli, T. F., Chandra, V., Krajmalnik‐Brown, R., Jewell, M., Li, L., Liao, C., McAllister, F. M., Nirmalkar, K., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2525478 · Cited by 34
Alonso, C. D., & Kamboj, M. (2014) · Current Infectious Disease Reports · doi:10.1007/s11908-014-0414-0 · Cited by 29
Liu, S., Zhu, X., Qiu, Y., Wang, L., Shang, X., Gao, K., Yang, X., & Jiang, Z. (2021) · Animals · doi:10.3390/ani11082186 · Cited by 31
Brevi, A., Cogrossi, L. L., Lorenzoni, M., Mattorre, B., & Bellone, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.845422 · Cited by 29
The microbiome in graft-versus-host disease: a tale of two ecosystems
Samarkhazan, H. S., Nouri, S., Maleknia, M., & Aghaei, M. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06797-5 · Cited by 30
Fuji, S., Kapp, M., & Einsele, H. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00089 · Cited by 28
Rayes, A., Morrow, A. L., Payton, L. R., Lake, K. E., Lane, A., & Davies, S. M. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.11.017 · Cited by 28
Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease
Kumari, R., Palaniyandi, S., & Hildebrandt, G. C. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5369-9 · Cited by 30
Shimizu, Y., Nakamura, K., Kikuchi, M., Ukawa, S., Nakamura, K., Okada, E., Imae, A., Nakagawa, T., Yamamura, R., Tamakoshi, A., et al. (2021) · GeroScience · doi:10.1007/s11357-021-00398-y · Cited by 32
Zeiser, R., Warnatz, K., Rosshart, S. P., Sagar, & Tanriver, Y. (2022) · European Journal of Immunology · doi:10.1002/eji.202149530 · Cited by 31
Vallet, N., Salmona, M., Malet-Villemagne, J., Bredel, M., Bondeelle, L., Tournier, S., Mercier‐Delarue, S., Cassonnet, S., Ingram, B. O., de Latour, R. P., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.06.009 · Cited by 29
TLR/MyD88-mediated Innate Immunity in Intestinal Graft-versus-Host Disease
Lee, Y.-K., Kang, M.-S., & Choi, E. Y. (2017) · Immune Network · doi:10.4110/in.2017.17.3.144 · Cited by 28
Weber, D., Frauenschläger, K., Ghimire, S., Peter, K., Panzer, I., Hiergeist, A., Weber, M., Kutny, D., Wolff, D., Grube, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185265 · Cited by 28
Bowerman, K. L., Varelias, A., Lachner, N., Kuns, R. D., Hill, G. R., & Hugenholtz, P. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1705729 · Cited by 26
Kelly, D. L., Lyon, D., Yoon, S. L., & Horgas, A. L. (2015) · Cancer Nursing · doi:10.1097/ncc.0000000000000286 · Cited by 28
Dubberke, E. R., Reske, K. A., Olsen, M. A. A., Bommarito, K. M., Seiler, S. M., Silveira, F. P., Chiller, T. M., DiPersio, J. F., & Fraser, V. J. (2017) · Transplantation Direct · doi:10.1097/txd.0000000000000662 · Cited by 27
The Mycobiome: Impact on Health and Disease States
El‐Jurdi, N., & Ghannoum, M. A. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0045-2016 · Cited by 27
Camargo, J. F., Anderson, A. D., Natori, Y., Natori, A., Morris, M. I., Pereira, D. L., & Komanduri, K. V. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020003277 · Cited by 26
Servais, S., Beguin, Y. P., Delens, L., Ehx, G., Fransolet, G., Hannon, M., Willems, É., Humblet‐Baron, S., Belle, L., & Baron, F. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1182498 · Cited by 26
Song, Q., Wang, X., Wu, X., Kang, T. H., Qin, H., Zhao, D., Jenq, R. R., van den Brink, M. R. M., Riggs, A. D., Martin, P. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21133-3 · Cited by 26
Self-citationRecent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease
Mohamed, F. A., Thangavelu, G., Rhee, S. Y., Sage, P. T., O’Connor, R. S., Rathmell, J. C., & Blazar, B. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.757836 · Cited by 26
Self-citationKnisely, A. T., Seo, Y. D., Wargo, J. A., & Chelvanambi, M. (2023) · Cancers · doi:10.3390/cancers15030777 · Cited by 26
A Characterization of the Oral Microbiome in Allogeneic Stem Cell Transplant Patients
Ames, N. J., Sulima, P., Ngo, T. D., Barb, J. J., Munson, P. J., Paster, B. J., & Hart, T. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047628 · Cited by 27
Solders, M., Erkers, T., Gorchs, L., Poiret, T., Remberger, M., Magalhaes, I., & Kaipe, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01861 · Cited by 27
Horton, L. E., Haste, N. M., & Taplitz, R. A. (2018) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-018-0435-0 · Cited by 26
Lyu, M., Zhou, Z., Wang, X., Lv, H., Wang, M., Pan, G., Wang, Y., Fan, G., Gao, X., Feng, Y., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01440 · Cited by 26
Applications of gut microbiota in patients with hematopoietic stem-cell transplantation
Yu, J., Sun, H., Cao, W., Han, L., Song, Y., Wan, D., & Jiang, Z. (2020) · Experimental Hematology & Oncology · doi:10.1186/s40164-020-00194-y · Cited by 25
Metadata
- Authors
- Jenq, R. R., Ubeda, C., Taur, Y., Menezes, C. C., Khanin, R., Dudakov, J. A., Liu, C., West, M. L., Singer, N. V., Equinda, M. J., Gobourne, A., Lipuma, L., Young, L. F., Smith, O. M., Ghosh, A., Hanash, A. M., Goldberg, J. D., Aoyama, K., Blazar, B. R., Pamer, E. G., & R.M. van den Brink, M.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Adult Bone Marrow Transplantation Service 1 and 2 ; and 3
- Cornell University (US)
- University of Florida (US)
- University of Minnesota (US)
- Corresponding author
- Jenq, Robert R.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2012-04-30
- Volume
- 209
- Issue
- 5
- Pages
- 903-911
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3348096
- OpenAlex
- W2131766513
- Cited by
- 626
- References
- 37
- Citations by year
- 2026: 15 · 2025: 35 · 2024: 23 · 2023: 45 · 2022: 55 · 2021: 53 · 2020: 58 · 2019: 48 · 2018: 51 · 2017: 67 · 2016: 61 · 2015: 40 · 2014: 43 · 2013: 22 · 2012: 10
- FWCI
- 14.69
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR000064, 4r37ai039031-21, 5k23ai095398-05)
- National Heart, Lung, and Blood Institute (R01HL056067, R01HL069929)
- National Cancer Institute (P01CA023766, P01CA142106, R01CA107096, P30CA008748)
- National Institute of Allergy and Infectious Diseases (R01AI034495, R37-AI039031, R01AI100288, R01AI080455, K23-AI095398, P01AI056299, R01AI042135)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- intestinal inflammation, gut microbiota, allogeneic bone marrow transplantation, graft-versus-host disease, Lactobacillus, Lactobacillales, Clostridiales, microbial diversity, microbiome manipulation, gut microbiota composition
- MeSH terms
- Ampicillin, Animals, Base Sequence, Enterocolitis, Feces, Graft vs Host Disease, Gram-Positive Bacteria, Humans, Molecular Sequence Data, Phylogeny, RNA, Ribosomal, 16S, Species Specificity, Transplantation, Homologous, Bone Marrow Transplantation, Dextran Sulfate, Sequence Analysis, DNA, Biodiversity, Mice, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review